End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5.030 CNY | -0.40% |
|
-7.54% | -1.76% |
Jun. 06 | Jointown Pharmaceutical Gets Drug Registration for Betamethasone Sodium Phosphate Injection | MT |
May. 19 | Jointown to Invest 23 Million Yuan Into Pharma-Focused Investment Fund | MT |
Projected Income Statement: Jointown Pharmaceutical Group Co., Ltd
Annual
Quarterly
Annual
Quarterly
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | 110,860 | 122,407 | 140,424 | 150,140 | 151,810 | 161,909 | 175,712 | 180,399 |
Change | - | 10.42% | 14.72% | 6.92% | 1.11% | 6.65% | 8.53% | 2.67% |
EBITDA 1 | 4,909 | 4,187 | 3,526 | 3,741 | 4,427 | 4,591 | 5,114 | 5,495 |
Change | - | -14.72% | -15.78% | 6.11% | 18.32% | 3.7% | 11.4% | 7.45% |
EBIT 1 | 4,352 | 3,593 | 2,853 | 3,023 | 3,635 | 3,917 | 4,147 | 4,573 |
Change | - | -17.46% | -20.58% | 5.95% | 20.26% | 7.75% | 5.88% | 10.27% |
Interest Paid 1 | -985.2 | -1,098 | -1,134 | -1,179 | -1,163 | -639.3 | -847.8 | -21 |
Earnings before Tax (EBT) 1 | 4,334 | 3,363 | 2,838 | 2,991 | 3,637 | 3,716 | 3,977 | 4,236 |
Change | - | -22.4% | -15.62% | 5.38% | 21.62% | 2.15% | 7.02% | 6.53% |
Net income 1 | 3,075 | 2,448 | 2,085 | 2,174 | 2,507 | 2,753 | 2,842 | 2,989 |
Change | - | -20.38% | -14.84% | 4.27% | 15.33% | 9.8% | 3.23% | 5.18% |
Announcement Date | 4/26/21 | 4/25/22 | 4/24/23 | 4/26/24 | 4/28/25 | - | - | - |
1CNY in Million
Estimates
Forecast Balance Sheet: Jointown Pharmaceutical Group Co., Ltd
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|---|
Net Debt 1 | 2,884 | 2,102 | -2,170 | -2,372 | -4,734 | -5,537 | -2,289 | -6,595 |
Change | - | -27.12% | -203.24% | -9.31% | -99.58% | -16.96% | 58.66% | -188.12% |
Announcement Date | 4/26/21 | 4/25/22 | 4/24/23 | 4/26/24 | 4/28/25 | - | - | - |
1CNY in Million
Estimates
Cash Flow Forecast: Jointown Pharmaceutical Group Co., Ltd
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|---|
CAPEX 1 | 1,158 | 1,215 | 1,083 | 885.4 | 952.6 | 1,335 | 1,402 | 1,628 |
Change | - | 4.86% | -10.88% | -18.22% | 7.59% | 40.14% | 5% | 16.14% |
Free Cash Flow (FCF) 1 | - | - | - | - | - | - | - | - |
Change | - | - | - | - | - | - | - | - |
Announcement Date | 4/26/21 | 4/25/22 | 4/24/23 | 4/26/24 | 4/28/25 | - | - | - |
1CNY in Million
Estimates
Forecast Financial Ratios: Jointown Pharmaceutical Group Co., Ltd
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|---|
Profitability | ||||||||
EBITDA Margin (%) | 4.43% | 3.42% | 2.51% | 2.49% | 2.92% | 2.84% | 2.91% | 3.05% |
EBIT Margin (%) | 3.93% | 2.93% | 2.03% | 2.01% | 2.39% | 2.42% | 2.36% | 2.54% |
EBT Margin (%) | 3.91% | 2.75% | 2.02% | 1.99% | 2.4% | 2.29% | 2.26% | 2.35% |
Net margin (%) | 2.77% | 2% | 1.48% | 1.45% | 1.65% | 1.7% | 1.62% | 1.66% |
FCF margin (%) | - | - | - | - | - | - | - | - |
FCF / Net Income (%) | - | - | - | - | - | - | - | - |
Profitability | ||||||||
ROA | 4.05% | 2.94% | 2.34% | 2.35% | 2.57% | 2.7% | 2.65% | 3% |
ROE | 15.9% | 11.37% | 8.98% | 9.04% | 9.98% | 8.99% | 9.44% | 8.98% |
Financial Health | ||||||||
Leverage (Debt/EBITDA) | 0.59x | 0.5x | - | - | - | - | - | - |
Debt / Free cash flow | - | - | - | - | - | - | - | - |
Capital Intensity | ||||||||
CAPEX / Current Assets (%) | 1.04% | 0.99% | 0.77% | 0.59% | 0.63% | 0.82% | 0.8% | 0.9% |
CAPEX / EBITDA (%) | 23.6% | 29.02% | 30.71% | 23.67% | 21.52% | 29.08% | 27.41% | 29.62% |
CAPEX / FCF (%) | - | - | - | - | - | - | - | - |
Items per share | ||||||||
Cash flow per share 1 | 0.683 | 0.686 | 0.7905 | 0.9416 | 0.6113 | 0.66 | 0.7567 | 0.83 |
Change | - | 0.44% | 15.24% | 19.1% | -35.08% | 7.97% | 14.65% | 9.69% |
Dividend per Share 1 | 0.1858 | 0.1115 | 0.1858 | 0.1938 | 0.2 | 0.2253 | 0.221 | 0.2179 |
Change | - | -40% | 66.66% | 4.3% | 3.2% | 12.64% | -1.91% | -1.41% |
Book Value Per Share 1 | 3.848 | 4.161 | 4.454 | 4.756 | 5.403 | 5.774 | 6.044 | 6.604 |
Change | - | 8.16% | 7.03% | 6.79% | 13.59% | 6.88% | 4.67% | 9.26% |
EPS 1 | 0.576 | 0.472 | 0.3976 | 0.4264 | 0.5 | 0.5451 | 0.5623 | 0.5934 |
Change | - | -18.07% | -15.75% | 7.23% | 17.27% | 9.02% | 3.16% | 5.53% |
Nbr of stocks (in thousands) | 4,925,621 | 4,921,006 | 4,963,416 | 4,911,693 | 4,911,693 | 4,986,434 | 4,986,434 | 4,986,434 |
Announcement Date | 4/26/21 | 4/25/22 | 4/24/23 | 4/26/24 | 4/28/25 | - | - | - |
1CNY
Estimates
2025 * | 2026 * | |
---|---|---|
P/E ratio | 9.23x | 8.95x |
PBR | 0.87x | 0.83x |
EV / Sales | 0.12x | 0.13x |
Yield | 4.48% | 4.39% |
More valuation ratios
* Estimated data
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Sell
Buy

Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
5.030CNY
Average target price
6.260CNY
Spread / Average Target
+24.45%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 600998 Stock
- Financials Jointown Pharmaceutical Group Co., Ltd
Select your edition
All financial news and data tailored to specific country editions